Annie SCHREIJER-PIERIK

10/10/2019 Foreign electoral interference and disinformation in national and European democratic processes ✓ Adopté ▲ Pour 10/10/2019 Foreign electoral interference and disinformation in national and European democratic processes ✓ Adopté ▲ Pour 10/10/2019 Foreign electoral interference and disinformation in national and European democratic processes ✓ Adopté ▲ Pour 10/10/2019 Employment and social policies of the euro area ✓ Adopté ▲ Pour 10/10/2019 The 2021-2027 multiannual financial framework and own resources: time to meet citizens' expectations ✗ Rejeté ▲ Pour 10/10/2019 Foreign electoral interference and disinformation in national and European democratic processes ✓ Adopté ▲ Pour 10/10/2019 Flexibility Instrument: adjustments to the amounts mobilised for 2019 to be used for migration, refugee inflows and security threats ✗ Rejeté ▼ Contre 10/10/2019 Employment and social policies of the euro area ✗ Rejeté ▼ Contre 10/10/2019 Employment and social policies of the euro area ✓ Adopté ▼ Contre 10/10/2019 Employment and social policies of the euro area ✗ Rejeté ▼ Contre 10/10/2019 Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole ✓ Adopté ▼ Contre 10/10/2019 The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron ✓ Adopté ▼ Contre 10/10/2019 The draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean A2704-12 (ACS-GMØØ5-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council ✓ Adopté ▼ Contre 10/10/2019 The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 × DAS-40278-9 and genetically modified maize combining two, three or four of the single events MON 89034, 1507, MON 88017, 59122 and DAS-40278-9 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council ✓ Adopté ▼ Contre 10/10/2019 The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MZHG0JG (SYN-ØØØJG-2), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council ✓ Adopté ▼ Contre 10/10/2019 The 2021-2027 multiannual financial framework and own resources: time to meet citizens' expectations ✗ Rejeté ▼ Contre 10/10/2019 The 2021-2027 multiannual financial framework and own resources: time to meet citizens' expectations ✓ Adopté ▼ Contre 10/10/2019 The 2021-2027 multiannual financial framework and own resources: time to meet citizens' expectations ✗ Rejeté ▼ Contre 10/10/2019 The 2021-2027 multiannual financial framework and own resources: time to meet citizens' expectations ✗ Rejeté ▼ Contre 10/10/2019 The 2021-2027 multiannual financial framework and own resources: time to meet citizens' expectations ✗ Rejeté ▼ Contre